Department of Medicine
Clinical Assistant Professor; Clinical Director - Division of Nephrology
Internal Medicine; Nephrology
My breadth of clinical practice is broad; I care for patients with a wide range of both acute and chronic renal diseases. This includes patients with electrolyte abnormalities, autoimmune and/or secondary glomerulonephritides and polycystic kidney disease as well as those who have undergone kidney transplantation. My training at the Weill Cornell Hypertension Center has provided me with focused training in the management of refractory, secondary and perinatal hypertension.Therefore, I also see patients with refractory or difficult-to-control hypertension even though they may not have kidney dysfunction. As medical director of the Erie County Medical Center (ECMC) Living Donor Kidney Transplant Program, I see many prospective living donor kidney candidates during their donor evaluation process, and I follow them in the post-operative period.
I see patients in a variety of inpatient and outpatient settings. I serve as the nephrology attending physician on the inpatient Renal Medicine and Renal Consultation services at ECMC as well as the Renal Consult service at the Buffalo Niagara Medical Campus (BNMC). My outpatient clinics include my weekly general UBMD Nephrology and Transplant clinics at ECMC and my weekly general UBMD Nephrology clinic at the Niagara Falls Renal Office. I care for both in-center and home hemodialysis as well as peritoneal dialysis (PD) patients receiving services at numerous dialysis centers located throughout Erie and Niagara Counties. I work with national and global kidney care groups such as Fresenius and Davita to provide care for my patients, and I serve as medical director for several of their Western New York dialysis centers.
My clinical research interests are also wide-ranging. I have particular interests in medication, chemotherapy and toxin-induced kidney injury. I have worked on a project that investigated the long-term renal impacts of the chemotherapy agent ifosfamide in adult cancer patients. I also have a research interest in autosomal dominant adult polycystic kidney disease (AD-PKD). I am involved in a multicenter clinical trial to compare the efficacy and safety of the drug Tolvaptan to determine if it can help to slow, or even halt the progression of renal cysts and thereby delay or prevent progression of end-stage kidney disease in people with AD-PKD.
I supervise and teach physicians at all stages of their training, including interns and residents from UB’s internal medicine residency program as well as fellows in UB’s nephrology training program. I supervise trainees on both the inpatient Renal Medicine and Renal Consult services and in the outpatient Renal and Hypertension Clinic and the outpatient Transplant Clinic. In addition to bedside teaching, I sometimes teach small group nephrology seminars for third- and fourth-year medical students rotating on their medicine clerkships. I also provide lectures for the internal medicine resident teaching program and for the nephrology fellowship teaching program.